Login / Signup

Cryopreservation of Pig Semen Using a Quercetin-Supplemented Freezing Extender.

Seonggyu BangBereket Molla TangaXun FangGyeonghwan SeongIslam Mohamed SaadeldinAhmad-Yar QamarSanghoon LeeKeun-Jung KimYun-Jae ParkAbdelbagi Hamad Talha NabeelIl-Jeoung YuAkila Dushyantha CoorayKyu Pil LeeJongki Cho
Published in: Life (Basel, Switzerland) (2022)
Reactive oxygen species (ROS) produced during freeze-thaw procedures cause oxidative damage to the sperm, reducing fertility. We aimed to improve the post-thaw quality of pig sperm by quercetin (QRN) supplementation to reduce the cryodamage associated with the freeze-thaw procedure. Four equal aliquots of pooled boar semen were diluted with a freezing extender supplemented with different concentrations of QRN (0, 25, 50, and 100 µM) and then were subjected to cryopreservation in liquid nitrogen. Semen analysis was performed following 7 days of cryopreservation. Results demonstrated that the semen samples supplemented with 50 µM QRN significantly improved the post-thaw sperm quality than those subjected to other supplementations ( p < 0.05). Semen samples supplemented with 50 µM QRN showed significantly improved plasma membrane functional integrity (47.5 ± 1.4 vs. 43.1 ± 4.1, 45.3 ± 1.7, and 44.1 ± 1.4) and acrosome integrity (73.6 ± 3.4 vs. 66.3 ± 2.4, 66.7 ± 3.6, and 68.3 ± 32.9) as compared to the control, 25 µM, and 100 µM QRN groups, respectively. The mitochondrial activity of the 50 µM QRN group was greater than control and 25 µM QRN groups (43.0 ± 1.0 vs. 39.1 ± 0.9 and 41.9 ± 1.0) but showed no difference with the 100 µM QRN group. Moreover, the 50 µM QRN group showed a higher sperm number displaced to 1 cm and 3 cm points in the artificial mucus than other groups. Therefore, supplementing the freezing extender with QRN can serve as an effective tool to reduce the magnitude of oxidative damage associated with sperm freezing.
Keyphrases
  • reactive oxygen species
  • cell death
  • quality improvement
  • minimally invasive
  • randomized controlled trial
  • clinical trial
  • open label
  • data analysis
  • childhood cancer